Guerra-Tapia A

Language: Spanish
References: 29
Page: 101-102
PDF size: 48.50 Kb.

Text Extraction

No abstract

REFERENCES

1. Ganceviciene R, Zouboulis CC. Isotretinoin: state of the art treatment for acne vulgaris. J Dtsch Dermatol Ges 2010; 8 (Suppl. 1): S47-59.

2. Lowenstein EB, Lowenstein EJ. Isotretinoin systemic therapy and the shadow cast upon dermatology’s downtrodden hero. Clin Dermatol 2011; 29: 652-61.

3. Lucek RW, Colburn WA. Clinical pharmacokinetics of the retinoids. Clin Pharmacokinet 1985; 10: 38-62.

4. Goulden V, Layton AM, Cunliffe WJ. Longterm safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol 1994; 131: 360-3.

5. Layton AM, Knaggs H, Taylor J, et al. Isotretinoin for acne vulgaris-ten years later: a safe and successful treatment. Br J Dermatol 1993; 129: 292-6.

6. Amichai B, Shemer A, Grunwald MH. Lowdose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006; 54: 644-6.

7. Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: Rapid increase from 1992 through 2000. J Am Acad Dermatol 2002; 46: 505-9.

8. Agarwal US, Besarwal RK, Bhola K. Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial. Indian J Dermatol Venereol Leprol 2011; 77: 688-94.

9. Georgarakis M, Zougrou F, Tzavara S, Kontopoulos G, Tsiptsios I. Comparative bioequivalence study of two isotretinoin soft gel capsule formulations in healthy male volunteers. Int J Clin Pharmacol Ther 2003; 41: 316-22.

10. Colburn WA, Gibson DM, Wiens RE, Hanigan JJ. Food increases the bioavailability of isotretinoin. J Clin Pharmacol 1983; 23: 534-9.

11. Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other disorders. Drugs 1984; 28: 6-37.

12. Colburn WA, Vane FM, Shorter HJ. Pharmacokinetics of isotretinoin and its major blood metabolite following a single oral dose to man. Eur J Clin Pharmacol 1983; 24: 689-94.

13. Hermes C. Praetel and B.M. Henz, Medium dose isotretinoin for the treatment of acne. J Eur Acad Dermatol Venereol 1998; 11: 117- 21.

14. Millan SB, Flowers FP, Sherertz EF. Isotre - tinoin. South Med J 1987; 80: 494-9.

15. http://www.drugs.com/pro/accutane.html#T_2

16. Perry MD, McEvoy GK. Isotretinoin: new therapy for severe acne. Clin Pharm 1983; 2: 12-9.

17. Peck GL, Olsen TG, Butkus D, Pandya M, Arnaud-Battandier J, Cross EG. Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study. J Am Acad Dermatol 1982; 6: 735-45.

18. Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg 2008; 27: 197-206.

19. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ et al.; Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (1 Suppl.): S1-37.

20. Accutane® (isotretinoin capsules). Roche Pharmaceuticals. AEC_43780_PI_N(1) PI Revised: January 2010 Copyright © 2000- 200x by Roche Laboratories Inc. All rights reserved.

21. James WC. Acne. N Engl J Med 2005; 352: 1463-72.

22. Haynes RB. Introduction. In: Haynes RB, Taylor DW, Sackett DI, editores. Compliance in health care. Baltimore: Johns Hopkins University Press; 1979.

23. OMS. Medicamentos: uso racional de los medicamentos. Nota descriptiva N.° 338. Mayo de 2010.

24. Morales Suárez-Varela MT. GEMECOR. Study on the use of a smart pillbox to improve treatment compliance. Aten Primaria 2009; 41: 185-91.

25. Shikiar R, Halpern MT, McGann M, Palmer CS, Seidlin M. The relation of pa tient satisfaction with treatment of otitis externa to clinical outcomes: deve lopment of an instrument. Clin Ther 1999; 21: 1091-104.

26. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 2004; 7: 204-15.

27. Morris LS, Schulz RM. Patient compliance— anoverview. J Clin Pharm Ther 1992; 17: 283-95.

28. Morris LS, Schulz RM. Medication compliance: the patient’s perspective. Clin Ther 1993; 15: 593-606.

29. Guerra-Tapia A. Estudio de satisfacción y calidad de vida en pacientes con acné tratados con isotretinoína oral. Monografía. Editorial Jarpyo Madrid, 2002.